NRX Pharmaceuticals
NRXP
NRXP
30 hedge funds and large institutions have $1.86M invested in NRX Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
30
Holding in Top 10
–
Calls
$58K
Puts
–
Top Buyers
| 1 | +$212K | |
| 2 | +$15.1K | |
| 3 | +$13.7K | |
| 4 |
Renaissance Technologies
New York
|
+$12.1K |
| 5 |
JP Morgan Chase
New York
|
+$5.44K |
Top Sellers
| 1 | -$84.5K | |
| 2 | -$40.9K | |
| 3 | -$13.8K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$12.6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6.67K |